Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2023 / Mar / Measuring the Storm
Analytical science Technology and innovation

Measuring the Storm

How a molybdenum disulfide diode-based biosensor detects elevated levels of TNF-alpha – a biomarker of cytokine storm risk

By Georgia Hulme 03/24/2023 News 2 min read

Share

Overproduction of cytokines can lead to a “cytokine storm” – an extreme inflammatory reaction triggered by numerous health conditions, including COVID-19, cardiovascular disease, rheumatoid arthritis, and Alzheimer’s disease. Detection of cytokine biomarkers at low concentrations can help diagnostic professionals to identify the risk earlier. And although existing methods – such as ELISA and mass spectroscopy – are extremely sensitive, they are expensive and time consuming. And that’s why a group of Canadian researchers developed a rapid, label-free, molybdenum disulfide (MoS2) diode-based biosensor that detects one particular cytokine: TNF-alpha (1).

“The sensor we are developing is simple to use and portable so it could potentially be used in a doctor’s office or in more remote areas where access to laboratories is limited,” says Michael Adachi, the project’s lead investigator. “The advantage of the diode sensor is its simple electrical readout and fabrication process,” he continues.

The geometric asymmetry makes the sensor highly sensitive to any changes that occur at the surface. Next, the sensor is functionalized with TNF-alpha binding aptamers. So, when a small volume of solution containing TNF-alpha comes into contact with the sensor, it interacts with the aptamers, causing an observable change in the electrical properties of the biosensor crystal. By measuring the electrical signal output, the concentration of the biomarker protein can be assessed. “These biomarkers are indicators that can help determine if a person may have or be at risk of developing a disease,” says Adachi. 

There may be potential for this method to be applied in the detection of other biomarker proteins, and in other diseases, such as Alzheimer’s. For now, the team is working to overcome the challenges of targeting one specific protein in a sea of interfering substances, including hormones and salts. Indeed the next phase of the current study will assess sensor performance using blood samples – which may demonstrate its potential for scalability in the future.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. T De Silva et al., Nat Commun, 13 (2022). PMID: 36535944

About the Author(s)

Georgia Hulme

Associate Editor for the Pathologist

More Articles by Georgia Hulme

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Analytical science
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Could ≠ Should
Analytical science
Could ≠ Should

January 20, 2022

1 min read

The need to prevent the ordering of unnecessary tests

Diamonds Are a Diagnostician’s Best Friend
Analytical science
Diamonds Are a Diagnostician’s Best Friend

February 8, 2022

1 min read

A diagnostic sensor for rapid, cost-effective, and accurate detection of SARS-CoV-2

Hunting the Unknown
Analytical science
Hunting the Unknown

February 22, 2022

1 min read

When it comes to human health, we cannot ignore unknown molecules simply because they present analytical challenges

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.